These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 33205060)

  • 1. Pharmacological Activation of Non-canonical NF-κB Signaling Activates Latent HIV-1 Reservoirs
    Pache L; Marsden MD; Teriete P; Portillo AJ; Heimann D; Kim JT; Soliman MSA; Dimapasoc M; Carmona C; Celeridad M; Spivak AM; Planelles V; Cosford NDP; Zack JA; Chanda SK
    Cell Rep Med; 2020 Jun; 1(3):100037. PubMed ID: 33205060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternate NF-κB-Independent Signaling Reactivation of Latent HIV-1 Provirus.
    Acchioni C; Remoli AL; Marsili G; Acchioni M; Nardolillo I; Orsatti R; Farcomeni S; Palermo E; Perrotti E; Barreca ML; Sabatini S; Sandini S; Parolin C; Lin R; Borsetti A; Hiscott J; Sgarbanti M
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31243131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maraviroc Is Associated with Latent HIV-1 Reactivation through NF-κB Activation in Resting CD4
    Madrid-Elena N; García-Bermejo ML; Serrano-Villar S; Díaz-de Santiago A; Sastre B; Gutiérrez C; Dronda F; Coronel Díaz M; Domínguez E; López-Huertas MR; Hernández-Novoa B; Moreno S
    J Virol; 2018 May; 92(9):. PubMed ID: 29444937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLR1/2 Agonist Enhances Reversal of HIV-1 Latency and Promotes NK Cell-Induced Suppression of HIV-1-Infected Autologous CD4
    Duan S; Xu X; Wang J; Huang L; Peng J; Yu T; Zhou Y; Cheng K; Liu S
    J Virol; 2021 Aug; 95(17):e0081621. PubMed ID: 34133900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo.
    Nixon CC; Mavigner M; Sampey GC; Brooks AD; Spagnuolo RA; Irlbeck DM; Mattingly C; Ho PT; Schoof N; Cammon CG; Tharp GK; Kanke M; Wang Z; Cleary RA; Upadhyay AA; De C; Wills SR; Falcinelli SD; Galardi C; Walum H; Schramm NJ; Deutsch J; Lifson JD; Fennessey CM; Keele BF; Jean S; Maguire S; Liao B; Browne EP; Ferris RG; Brehm JH; Favre D; Vanderford TH; Bosinger SE; Jones CD; Routy JP; Archin NM; Margolis DM; Wahl A; Dunham RM; Silvestri G; Chahroudi A; Garcia JV
    Nature; 2020 Feb; 578(7793):160-165. PubMed ID: 31969707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation.
    Yang HC; Xing S; Shan L; O'Connell K; Dinoso J; Shen A; Zhou Y; Shrum CK; Han Y; Liu JO; Zhang H; Margolick JB; Siliciano RF
    J Clin Invest; 2009 Nov; 119(11):3473-86. PubMed ID: 19805909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV latency in the humanized BLT mouse.
    Marsden MD; Kovochich M; Suree N; Shimizu S; Mehta R; Cortado R; Bristol G; An DS; Zack JA
    J Virol; 2012 Jan; 86(1):339-47. PubMed ID: 22072769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiostrepton Reactivates Latent HIV-1 through the p-TEFb and NF-κB Pathways Mediated by Heat Shock Response.
    Peng W; Hong Z; Chen X; Gao H; Dai Z; Zhao J; Liu W; Li D; Deng K
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32094131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SMAC Mimetic Plus Triple-Combination Bispecific HIVxCD3 Retargeting Molecules in SHIV.C.CH505-Infected, Antiretroviral Therapy-Suppressed Rhesus Macaques.
    Dashti A; Waller C; Mavigner M; Schoof N; Bar KJ; Shaw GM; Vanderford TH; Liang S; Lifson JD; Dunham RM; Ferrari G; Tuyishime M; Lam CK; Nordstrom JL; Margolis DM; Silvestri G; Chahroudi A
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32817214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV Replication and Latency in a Humanized NSG Mouse Model during Suppressive Oral Combinational Antiretroviral Therapy.
    Satheesan S; Li H; Burnett JC; Takahashi M; Li S; Wu SX; Synold TW; Rossi JJ; Zhou J
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29343582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small Molecule Inhibitors of BAF; A Promising Family of Compounds in HIV-1 Latency Reversal.
    Stoszko M; De Crignis E; Rokx C; Khalid MM; Lungu C; Palstra RJ; Kan TW; Boucher C; Verbon A; Dykhuizen EC; Mahmoudi T
    EBioMedicine; 2016 Jan; 3():108-121. PubMed ID: 26870822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of JAK1/2 Inhibitors on HIV Reservoir Using Primary Lymphoid Cell Model of HIV Latency.
    de Armas LR; Gavegnano C; Pallikkuth S; Rinaldi S; Pan L; Battivelli E; Verdin E; Younis RT; Pahwa R; Williams SL; Schinazi RF; Pahwa S
    Front Immunol; 2021; 12():720697. PubMed ID: 34531866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inhibitor apoptosis protein antagonist Debio 1143 Is an attractive HIV-1 latency reversal candidate.
    Bobardt M; Kuo J; Chatterji U; Chanda S; Little SJ; Wiedemann N; Vuagniaux G; Gallay PA
    PLoS One; 2019; 14(2):e0211746. PubMed ID: 30716099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BIRC2/cIAP1 Is a Negative Regulator of HIV-1 Transcription and Can Be Targeted by Smac Mimetics to Promote Reversal of Viral Latency.
    Pache L; Dutra MS; Spivak AM; Marlett JM; Murry JP; Hwang Y; Maestre AM; Manganaro L; Vamos M; Teriete P; Martins LJ; König R; Simon V; Bosque A; Fernandez-Sesma A; Cosford ND; Bushman FD; Young JA; Planelles V; Chanda SK
    Cell Host Microbe; 2015 Sep; 18(3):345-53. PubMed ID: 26355217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic Reactivation of Latent HIV Expression by Ingenol-3-Angelate, PEP005, Targeted NF-kB Signaling in Combination with JQ1 Induced p-TEFb Activation.
    Jiang G; Mendes EA; Kaiser P; Wong DP; Tang Y; Cai I; Fenton A; Melcher GP; Hildreth JE; Thompson GR; Wong JK; Dandekar S
    PLoS Pathog; 2015 Jul; 11(7):e1005066. PubMed ID: 26225771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzotriazoles Reactivate Latent HIV-1 through Inactivation of STAT5 SUMOylation.
    Bosque A; Nilson KA; Macedo AB; Spivak AM; Archin NM; Van Wagoner RM; Martins LJ; Novis CL; Szaniawski MA; Ireland CM; Margolis DM; Price DH; Planelles V
    Cell Rep; 2017 Jan; 18(5):1324-1334. PubMed ID: 28147284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo analysis of the effect of panobinostat on cell-associated HIV RNA and DNA levels and latent HIV infection.
    Tsai P; Wu G; Baker CE; Thayer WO; Spagnuolo RA; Sanchez R; Barrett S; Howell B; Margolis D; Hazuda DJ; Archin NM; Garcia JV
    Retrovirology; 2016 May; 13(1):36. PubMed ID: 27206407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactivation of HIV latency by a newly modified Ingenol derivative via protein kinase Cδ-NF-κB signaling.
    Jiang G; Mendes EA; Kaiser P; Sankaran-Walters S; Tang Y; Weber MG; Melcher GP; Thompson GR; Tanuri A; Pianowski LF; Wong JK; Dandekar S
    AIDS; 2014 Jul; 28(11):1555-66. PubMed ID: 24804860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxaliplatin antagonizes HIV-1 latency by activating NF-κB without causing global T cell activation.
    Zhu X; Liu S; Wang P; Qu X; Wang X; Zeng H; Chen H; Zhu H
    Biochem Biophys Res Commun; 2014 Jul; 450(1):202-7. PubMed ID: 24878527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HIV Latency Reversal Agent HODHBt Enhances NK Cell Effector and Memory-Like Functions by Increasing Interleukin-15-Mediated STAT Activation.
    Macedo AB; Levinger C; Nguyen BN; Richard J; Gupta M; Cruz CRY; Finzi A; Chiappinelli KB; Crandall KA; Bosque A
    J Virol; 2022 Aug; 96(15):e0037222. PubMed ID: 35867565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.